Answers are grounded in this paper and cite their sources.
Dravet syndrome is a severe, intractable epilepsy in which 80 % of patients have a de novo mutation in the gene SCN1A . We recently reported that a high seizure burden increased hippocampal concentrations of an array of pro-inflammatory prostaglandins in the Scn1a +/- mouse model of Dravet syndrome. This raised the possibility that a high seizure burden might also trigger the accumulation of specialized pro-resolving mediators that facilitate the resolution of neuroinflammation and brain repair. The present study therefore aimed to examine whether a high seizure burden increased hippocampal concentrations of various specialized pro-resolving mediators in the Scn1a +/- mouse model of Dravet syndrome. Scn1a +/- mice at postnatal day 21 (P21) were primed with a single hyperthermia-induced seizure event to induce a high seizure burden. On P24 primed Scn1a +/- mice with a high seizure burden, unprimed naïve Scn1a +/- mice and wild-type (WT) mice were euthanized and hippocampal tissue was collected for analysis of various specialized pro-resolving mediators using liquid chromatography mass spectrometry. Scn1a +/- mice with a high seizure burden showed increased hippocampal concentrations of the pro-inflammatory leukotrienes B4 and E4. Further, a high seizure burden increased hippocampal concentrations of various special pro-resolving mediators, including the maresins (maresin1), D-series resolvins (RVD1 and RVD4), and protectin (PCTR1). To further characterize these changes, we determined the mRNA expression of lipoxygenase genes, as these synthetic enzymes are common across classes of specialized pro-resolving mediators. However, hippocampal expression of Alox5 , Alox12 and Alox15 were not influenced by a high seizure burden. We report for the first time that a high seizure burden increases the hippocampal concentrations of various specialized pro-resolving mediators in Scn1a +/- mice. This provides a platform for future studies to examine whether modulation of these mediators might be exploited to reduce seizures and facilitate brain repair in intractable epilepsy syndromes. • Specialized pro-resolving mediators are endogenous mediators that actively resolve neuroinflammation and enhance brain repair. • The high seizure burden in the Scn1a +/- mouse model of Dravet syndrome increased the production of pro-inflammatory mediators leukotriene B4 and E4. • The high seizure burden also increased hippocampal concentrations of an array of pro-resolving mediators including mediators in the maresin, resolvin and protectin classes. • Future studies could examine whether these mediators reduce seizures and enhance brain repair in the Scn1a +/- mice.
No takes yet. Share an insight, caveat, or question.
Yip et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: